88IV - Public company info - Viva Biotech Holdings

Input the stock code or the company name

Viva Biotech Holdings, 01873.HK - Cash Flow	2019-12	2018-12	2017-12	2016-12
Net Cash Flow from Operating Activities	62,307	16,610	34,544	23,285
Net Cash Flow from Return on Investments & Servicing of Finance	-121,219	407	172	-127
Interest Received	14,904	964	348	76
Interest Paid	-288	-557	-176	-203
Dividend Received	0	0	0	0
Dividend Paid	-135,835	0	0	0
Others	0	0	0	0
Taxes (Paid) / Refunded	-16,295	-4,500	-6,653	-2,167
Net Cash Flow from Investing Activities	-304,959	-70,913	-10,110	-19,665
Additions to Fixed Assets	-61,827	-46,903	-18,923	-7,341
Disposal of Fixed Assets	49	65	0	588
Increase in Investments	-1,801,917	-101,099	-50,800	-13,520
Decrease in Investments	1,619,156	74,545	40,800	0
Net Cash Flow with Related Parties	0	-14,922	0	0
Others	-60,420	17,401	18,813	608
Net Cash Flow before Financing Activities	-380,166	-58,396	17,953	1,326
Net Cash Flow from Financing Activities	1,120,987	180,036	-673	-538
New Loans	20,630	0	0	0
Loans Repayment	-36,672	-471	-673	-538
Fixed Income/Debt Instruments	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0
Equity Financing	1,269,469	195,429	0	0
Net Cash Flow with Related Parties	0	-14,922	0	0
Others	-132,440	0	0	0
Increase(Decrease) in Cash & Cash Equivalents	740,821	121,640	17,280	788
Cash & Cash Equivalents at Beginning of Year	155,554	29,766	13,425	12,013
Net Cash Flow due to Change in Exchange Rate/Others	7,716	4,148	-939	624
Cash & Cash Equivalents at End of Year	904,091	155,554	29,766	13,425
Currency	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	0	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Viva Biotech Holdings , 01873.HK